Marchex, Inc. filings document the regulatory record for a Delaware operating company that provides AI-based conversational intelligence and analytics solutions. Its disclosures cover operating and financial results, material agreements, capital-structure matters, governance actions, legal proceedings, and risk factors tied to its conversational analytics business.
Recent filings include Form 8-K material-event reports, proxy materials for annual meeting matters, and compensation disclosures involving cash awards, restricted stock units, stock options, and the 2021 Stock Incentive Plan. The filings also describe the company's Class A and Class B common stock voting structure, board and stockholder voting matters, lease-related agreements and impairments, and settlement documentation for civil litigation.
Marchex reported third-quarter 2026 revenue of $16.0 million, up from $15.2 million a year earlier, and GAAP net income of $1.3 million versus a $1.3 million loss. Adjusted EBITDA was $2.4 million, including $0.2 million of reorganization and acquisition-related costs, compared with $0.5 million; before those costs it was $2.6 million. Nine-month revenue was $45.874 million versus $49.039 million in 2025.
Following its July 2026 acquisition of Archenia, Marchex described early commercial activity: an existing customer began commercial AI Voice Agent deployment after a paid pilot; the relationship generates approximately $400,000 in annualized revenue and is expected to produce more than $200,000 in incremental annualized revenue in 2027. A major automotive OEM approved Engage for Service through its dealer portal after a pilot involving 75 dealerships. Travis Fairchild was appointed president effective November 9, 2026.
For the fourth quarter of 2026, Marchex anticipates revenue of $15.0 million or more and adjusted EBITDA, net of reorganization and acquisition costs, of $2.3 million to $2.5 million. It cited typical seasonal declines in conversational volumes and said its initial 2027 outlook is currently anticipated in early March 2027.
Marchex Inc. President Travis Fairchild received two restricted stock unit awards, each covering 400,000 units, effective November 9, 2026. The first award vests in full on the third anniversary of the grant date and the second on the fifth anniversary. Each unit represents the right to receive one share of Class B Common Stock upon vesting.
On November 9, 2026, Marchex Inc. President Travis Fairchild reported direct holdings of 244,426 Class B common shares, options covering 60,000 shares at $4.27 expiring March 7, 2029, and convertible debt plus accrued interest convertible into 558,809 Class B shares at $1.80. The debt carries 6% interest; its $990,991 principal is payable in three equal tranches on the 12-, 18- and 24-month anniversaries of July 1, 2026, and $14,865 in accrued interest had accumulated.
Marchex, Inc. (MCHX) appointed Travis Fairchild president effective November 9, 2026; he will also serve as Co-Principal Executive Officer for SEC reporting. Fairchild was CEO of Archenia, Inc., which Marchex acquired in July 2026, and previously spent 18 years at Marchex in strategy and business development. Troy Hartless, the prior president, will continue as chief revenue officer, focused on new and emerging opportunities and sales channels.
Fairchild’s annual base salary will be $400,000. His appointment includes two awards of 400,000 RSUs each, vesting in full on the third and fifth anniversaries of the grant date, respectively; each RSU represents the right to receive one Class B common share upon vesting. Following a Change in Control, a company termination without Cause or Fairchild’s termination for Good Reason provides a lump sum of 12 months of base salary plus any earned prior-calendar-year bonus, capped at 100% of then annual salary, and 12 months of COBRA benefits. Termination due to death or disability provides 18 months of COBRA benefits. The terms also provide immediate vesting of all unvested time-based and performance options, restricted stock and RSUs in the event of a Change in Control, a company termination without Cause, or termination due to death or disability before a Change in Control.
Marchex, Inc. (MCHX) is asking stockholders to elect five directors, ratify RSM US LLP as auditor for fiscal 2026, approve named executive officer compensation in a non-binding vote, and choose how often future compensation votes will occur. The board recommends FOR the nominees, auditor ratification and compensation proposal, and a three-year frequency. The meeting is scheduled for December 16, 2026; holders of record on October 21, 2026 are eligible to vote.
Each Class A share carries 25 votes and each Class B share one vote. As of October 21, 2026, Chairman Russell Horowitz was listed as beneficially owning 100.0% of Class A common stock and 77.3% of total voting power. Director nominee Dennis Cline's biography states he filed a voluntary Chapter 7 petition in October 2026.
Marchex, Inc. reported revenue of $11.0 million for the quarter and $21.6 million for the six months ended June 30 2026, down from $11.7 million and $23.1 million a year earlier. The company posted a quarterly net loss applicable to common stockholders of $0.4 million and a six‑month net loss of $2.1 million, with basic and diluted loss per share of $0.01 for the quarter and $0.05 year‑to‑date.
Total operating expenses declined year‑over‑year, driven mainly by lower sales and marketing, product development, and general and administrative costs following reorganizations, partially offset by higher depreciation and costs tied to new customer pilots. Cash and cash equivalents were $8.2 million at June 30 2026, with total assets of $37.6 million and total liabilities of $8.6 million.
On July 1 2026, Marchex closed the acquisition of Archenia, Inc., issuing $10.0 million of 6% convertible promissory notes payable over 24 months, convertible into Class B shares at $1.80 per share. Additional contingent consideration of up to 4.0 million Class B shares may be issued based on Archenia’s post‑closing performance and integration targets.
Marchex, Inc. reported second-quarter 2026 revenue of $11.0 million, down modestly from $11.7 million a year earlier. The company recorded a net loss of $0.4 million, or $(0.01) per diluted share, versus net income of $0.1 million in the prior-year quarter. Adjusted EBITDA improved to $0.7 million from $0.6 million, and excluding $1.0 million of reorganization and acquisition-related costs, adjusted EBITDA was $1.7 million.
The acquisition of Archenia closed on July 1, 2026, so Q2 results exclude Archenia, but supplemental pro forma figures show combined Q2 2026 revenue of $15.5 million and adjusted EBITDA of $1.0 million (or $2.0 million before reorganization and acquisition costs). For Q3 2026, Marchex anticipates pro forma combined revenue of $16.0–$16.5 million and adjusted EBITDA (net of reorganization and acquisition costs) of $2.3–$2.5 million. Management highlights early momentum selling combined Marchex–Archenia AI-driven products, citing customer wins that expand annualized revenue with key home services, auto services, and advertising/media clients.
Russell C. Horowitz, founder and chairman of Marchex, Inc., filed a Schedule 13D reporting beneficial ownership of 8,813,485 shares of Marchex Class B common stock, or 18.5% of the class, based on shares outstanding as of April 10, 2026.
This total includes Class A common shares convertible into Class B, stock options, and shares issuable upon conversion of $4.9 million of convertible promissory notes acquired on July 1, 2026. Those notes are initially convertible into 2,702,703 shares at $1.80 per share, issued as consideration in Marchex’s stock purchase of Archenia, Inc.
Marchex, Inc. chairman and ten percent owner Russell C. Horowitz reported receiving $4,864,865 of 6.0% convertible debt due 2028 in connection with Marchex’s acquisition of privately held Archenia, Inc. The notes were granted on July 1, 2026 under a stock purchase agreement.
The convertible notes bear 6% interest and are payable in three equal tranches on the 12-, 18- and 24-month anniversaries of the closing. They are convertible into up to 2,702,703 shares of Marchex Class B common stock at $1.80 per share. The agreement also entitles Horowitz to receive 972,973 additional shares for each of the first and second 12‑month periods after closing if Archenia meets specified revenue or Adjusted EBITDA thresholds and integration or customer retention targets, with this earn-out right fixed and irrevocable as of the closing date.